drugset
drugset / Trial / NCT06918743

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

NCT06918743 ↗

Phase 2 Not yet recruiting 147 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of RSS0393 ointment in patients with plaque psoriasis Phase II study

Timeline

Start
2025-04
Primary completion
2026-03
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Subject RSS0393 Unknown 0.01 % Other
Subject RSS0393 Unknown 0.03 % Other

Indications

psoriasis